Overcoming Primary Resistance to Immunotherapy in Metastatic Melanoma

Clinical trial NCT05304546 · COMPLETED

Trial details

NCT number: NCT05304546
Sponsor: Dr. Ronnie Shapira
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma Metastatic Melanoma Immunotherapy BRAF V600E Malignant Melanoma Stage IV

Start date: 2023-09-05
Primary completion: 2025-07-17
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.